ENTRY       D11841                      Drug
NAME        Vibecotamab (USAN/INN)
FORMULA     C5629H8669N1503O1738S38
EXACT_MASS  126345.5557
MOL_WEIGHT  126423.5595
SEQUENCE    (A chain)
            QVQLQQSGAE VKKPGASVKV SCKASGYTFT DYYMKWVKQS HGKSLEWMGD IIPSNGATFY
            NQKFKGKATL TVDRSTSTAY MELSSLRSED TAVYYCARSH LLRASWFAYW GQGTLVTVSS
            ASTKGPSVFP LAPSSKSTSG GTAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS
            GLYSLSSVVT VPSSSLGTQT YICNVNHKPS DTKVDKKVEP KSCDKTHTCP PCPAPPVAGP
            SVFLFPPKPK DTLMISRTPE VTCVVVDVKH EDPEVKFNWY VDGVEVHNAK TKPREEEYNS
            TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV YTLPPSREEM
            TKNQVSLTCD VSGFYPSDIA VEWESDGQPE NNYKTTPPVL DSDGSFFLYS KLTVDKSRWE
            QGDVFSCSVM HEALHNHYTQ KSLSLSPGK
            (B chain)
            DFVMTQSPDS LAVSLGERAT INCKSSQSLL NTGNQKNYLT WYQQKPGQPP KLLIYWASTR
            ESGVPDRFTG SGSGTDFTLT ISSLQAEDVA VYYCQNDYSY PYTFGGGTKL EIKRTVAAPS
            VFIFPPSDEQ LKSGTASVVC LLNNFYPREA KVQWKVDNAL QSGNSQESVT EQDSKDSTYS
            LSSTLTLSKA DYEKHKVYAC EVTHQGLSSP VTKSFNRGEC
            (C chain)
            EVQLVESGGG LVQPGGSLRL SCAASGFTFS TYAMNWVRQA PGKGLEWVGR IRSKYNNYAT
            YYADSVKGRF TISRDDSKNT LYLQMNSLRA EDTAVYYCVR HGNFGDSYVS WFAYWGQGTL
            VTVSSGKPGS GKPGSGKPGS GKPGSQAVVT QEPSLTVSPG GTVTLTCGSS TGAVTTSNYA
            NWVQQKPGKS PRGLIGGTNK RAPGVPARFS GSLLGGKAAL TISGAQPEDE ADYYCALWYS
            NHWVFGGGTK LTVLEPKSSD KTHTCPPCPA PPVAGPSVFL FPPKPKDTLM ISRTPEVTCV
            VVDVKHEDPE VKFNWYVDGV EVHNAKTKPR EEQYNSTYRV VSVLTVLHQD WLNGKEYKCK
            VSNKALPAPI EKTISKAKGQ PREPQVYTLP PSREQMTKNQ VKLTCLVKGF YPSDIAVEWE
            SNGQPENNYK TTPPVLDSDG SFFLYSKLTV DKSRWQQGNV FSCSVMHEAL HNHYTQKSLS
            LSPGK
            (Disulfide bridge: A22-A96, A147-A203, A223-B220, A229-C265, A232-C268, A263-A323, A369-A427, B23-B94, B140-B200,  C22-C98, C167-C235, C299-C359, C405-C463)
  TYPE      Peptide
EFFICACY    Antineoplastic, Immunomodulator
  TYPE      Monoclonal antibody, bispecific antibody
TARGET      IL3RA (CD123) [HSA:3563] [KO:K04737]
            CD3E [HSA:916] [KO:K06451]
  PATHWAY   hsa04640(3563+916)  Hematopoietic cell lineage
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               Interleukin receptors
                IL3RA (CD123)
                 D11841  Vibecotamab (USAN/INN)
             Cell surface molecules and ligands
              Other cell surface molecules
               CD molecules
                CD3E
                 D11841  Vibecotamab (USAN/INN)
DBLINKS     CAS: 2138442-13-2
///
